M&A Deal Summary

Charles River Laboratories International Acquires Inveresk Research Group

On July 4, 2004, Charles River Laboratories International acquired life science company Inveresk Research Group for 1.5B USD

Acquisition Highlights
  • This is Charles River Laboratories International’s 1st transaction in the Life Science sector.
  • This is Charles River Laboratories International’s largest (disclosed) transaction.
  • This is Charles River Laboratories International’s 1st transaction in the United States.
  • This is Charles River Laboratories International’s 1st transaction in North Carolina.

M&A Deal Summary
Date 2004-07-04
Target Inveresk Research Group
Sector Life Science
Buyer(s) Charles River Laboratories International
Deal Type Add-on Acquisition
Deal Value 1.5B USD
Advisor(s) Goldman Sachs (Financial)
Clifford Chance (Legal)

Target

Inveresk Research Group

Cary, North Carolina, United States
Inveresk Research Group, Inc. is a provider of drug development services to companies in the pharmaceutical and biotechnology industries. Through its Pre-clinical and Clinical business segments, the Company offers a broad range of drug development services, including pre-clinical safety and pharmacology evaluation services, laboratory sciences services and clinical development services.

Search 200,577 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Charles River Laboratories International

Wilmington, Massachusetts, United States
Category Company
Founded 1947
Sector Life Science
Employees20,400
Revenue 4.1B USD (2023)
DESCRIPTION

Charles River Laboratories International is a provider of essential products and contract services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. Charles River Laboratories International was incorporated in 1947 and is based in Wilmington, Massachusetts.

DEAL STATS #
Overall 1 of 31
Sector (Life Science) 1 of 28
Type (Add-on Acquisition) 1 of 26
State (North Carolina) 1 of 2
Country (United States) 1 of 20
Year (2004) 1 of 1
Size (of disclosed) 1 of 17
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2008-09-09 NewLab BioQuality AG

Dusseldorf, Germany

NewLab BioQuality AG is a provider of safety and quality control services to biopharmaceutical clients.

Buy -
Mergr

Product

Company

Legal